Abstract
Copper-62 labeled diacetyl-bis (N 4-methylthiosemicarbazone) (62Cu-ATSM) has been proposed as a generator produced positron-emitting tracer for hypoxic tissue imaging. To clarify the usefulness of62Cu-ATSM for myocardial ischemia,62Cu-ATSM PET was performed in 7 patients with coronary artery disease. Increased myocardial uptake of62Cu-ATSM was observed (myocardium/blood ratio: 3.09) in one patient with unstable angina, who had increased18F-fluorodeoxyglucose (18F-FDG) uptake under the fasting condition. The other 6 patients, who were clinically stable, did not have increased62Cu-ATSM uptake, although abnormal18F-FDG uptake was seen in 4 patients. This preliminary study suggests that62Cu-ATSM is a promising PET tracer for hypoxic imaging in acute ischemia.
References
Chapman JD, Baer K, Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.Cancer Res 1983; 43: 1523–1528.
Hoffman JM, Rasey JS, Spence AM, Shaw DW, Krohn KA. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.Stroke 1987; 18 (1): 168–176.
Shelton ME, Dence CS, Hwang DR, Welch MJ, Bergmann SR. Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium.J Nucl Med 1989; 30 (3): 351–358.
Mannan RH, Somayaji VV, Lee J, Mercer JR, Chapman JD, Wiebe LI. Radiolabeled 1-(5-iodo-5-deoxy-ß-d-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.J Nucl Med 1991; 32: 1764–1770.
Martin GV, Biskupiak JE, Caldwell JH, Rasey JS, Krohn KA. Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia.J Nucl Med 1993; 34 (6): 918–924.
Linder KE, Chan YW, Cyr JE, Malley MF, Nowotnik DP, Nunn AD. Technetium-O(PnAO-(2-nitroimidazole)) [BMS181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis characterization and xanthine oxidase-catalyzed reduction.J Med Chem 1994; 37: 9–17.
Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.Int J Radiat Oncol Biol Phys 1992; 22: 199–212.
Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.J Nucl Med 1997; 38: 1155–1160.
Fujibayashi Y, Taniuchi H, Wada A, Yonekura Y, Konishi J, Yokoyama A. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N 4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.Ann Nucl Med 1995; 9: 1–5.
Fujibayashi Y, Cutler CS, Anderson CJ, McCarthy DW, Jones LA, Sharp T, et al. Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model:ex vivo imaging of hypoxia in rats.Nucl Med Biol 1999; 26: 117–121.
Matsumoto K, Fujibayashi Y, Yonekura Y. Application of the new zinc-62/copper-62 generator: an effective labeling method for62Cu-PTSM.Nucl Med Biol 1992; 19: 39–44.
Gingas BA, Suprunchuk T, Bayley CH. The preparation of some thiosemicarbazones and their copper compelxes. Part III.Can J Chem 1962; 40: 1053–1059.
DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner.J Nucl Med 1994; 35: 1398–1406.
Takahashi N, Fujibayashi Y, Yonekura Y, Welch MJ, Waki A, Tsuchida T, et al. Evaluation of62Cu labeled diacetylbis (N 4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.Ann Nucl Med 2000; 14: 323–328.
Nakano A, Lee JD, Shimizu H, Tsuchida T, Yonekura Y, Ishii Y, et al. Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction.J Am Coll Cardiol 1999; 33: 620–626.
Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the “hibernating myocardium.”J Am Coll Cardiol 1986; 8: 1467–1470.
Martin GV, Caldwell JH, Graham MM, Grierson JR, Kroll K, Cowan MJ, et al. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.J Nucl Med 1992; 33: 2202–2208.
Shi CQX, Sinusas AJ, Dione DP, Singer MJ, Young LH, Heller EN, et al. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia.J Nucl Med 1995; 36: 1078–1086.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takahashi, N., Fujibayashi, Y., Yonekura, Y. et al. Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia. Ann Nucl Med 15, 293–296 (2001). https://doi.org/10.1007/BF02987849
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02987849